New approaches to neglected cutaneous leishmaniasis: three-dimensional (3D) skin models and miRNA
Cutaneous leishmaniasis (CL) is a neglected tropical disease caused by protozoan parasites of the genus Leishmania. Transmitted through the bite of infected female phlebotomine sand flies, this disease affects both humans and animals.
Dogs play a central role in the epidemiology of leishmaniasis, acting as the main reservoir host. In canine cutaneous leishmaniosis (canCL), infection leads to painful skin lesions, ulceration, and bleeding, significantly compromising animal welfare and quality of life.
At the core of disease development lies the complex interaction between the parasite and the host immune system. Understanding these interactions is critical for identifying mechanisms of infection establishment, immune evasion, and disease progression.
In recent years, increased mobility of companion animals, coupled with climate and environmental changes, has contributed to the spread of both vectors and parasites, including non-endemic Leishmania species. This evolving scenario highlights the urgent need for integrated research strategies under the One Health framework, recognizing the interconnected health of humans, animals, and ecosystems.
Objective
miL3DSkin aims to study the early stages of Leishmania infection and the host immune response. A particular focus will be placed on:
- The role of extracellular vesicles (EVs) as mediators of parasite–host communication
- The function of microRNAs (miRNAs) in regulating host immune responses during infection
By integrating these elements, miL3Dskin team seeks to uncover molecular mechanisms that determine infection outcomes and disease progression in dogs.
Innovation
miL3DSkin introduces a pioneering and integrative approach to the study of canine cutaneous leishmaniosis (canCL), by combining:
- 3D tissue-engineered skin models, which closely mimic the structure and function of living tissue
- Extracellular vesicle (EVs) biology, an emerging field revealing new modes of intercellular communication
- miRNA profiling, enabling detailed analysis of gene regulation during infection
The project will follow a multidisciplinary strategy integrating cell biology, molecular biology, and immunology. This approach not only improves biological relevance but also aligns with ethical efforts to reduce animal experimentation while enhancing data quality.
Ultimately, miL3DSkin may contribute to the development of innovative, affordable, and effective strategies to prevent and control leishmaniasis, promoting healthier communities and ecosystems.
By removing blood from the equation, BLOODless significantly reduces the risk of accidentally introducing pathogens into mosquito colonies—an essential advantage for public health programs and research settings. Its long shelf life and ease of storage make it especially valuable in remote or resource-limited environments where malaria is most prevalent.
Who Can Benefit
-
Insectaries and vector biology research labs
-
Organizations developing malaria vaccines or genetically modified mosquitoes
-
Vector control programs in malaria-endemic regions
-
Public health agencies and nonprofits focused on disease elimination

Contact & Collaboration
We’re actively seeking licensing partners, co-development collaborators, and organizations interested in implementing BLOODLESS in large-scale mosquito rearing or disease control programs.
Whether you’re in research, public health, biotech, or working in malaria-endemic regions, we’d love to hear from you.
📩 Get in touch:
Email us at bloodless@ihmt.unl.pt or find us at NOVA INNOVATION and IHMT-NOVA.




